Temporal Dynamics of Antidepressant Ketamine Effects on Glutamine Cycling Follow Regional Fingerprints of AMPA and NMDA Receptor Densities

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Neuropsychopharmacology

• Publication date

  2017-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/npp.2016.184PMID 27604568PMCID PMC5437874
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• NMDAR inhibition-independent antidepressant actions of ketamine metabolites

  2016cited by this paper
• Effects of ketamine on cognition-emotion interaction in the brain

  2016cited by this paper
• The trouble with quality filtering based on relative Cramér‐Rao lower bounds

  2016cited by this paper
• A Pilot In Vivo Proton Magnetic Resonance Spectroscopy Study of Amino Acid Neurotransmitter Response to Ketamine Treatment of Major Depressive Disorder

  2015cited by this paper
• Automatic voxel positioning for MRS at 7 T

  2015cited by this paper
• Reduced density of glutamine synthetase immunoreactive astrocytes in different cortical areas in major depression but not in bipolar I disorder

  2015cited by this paper
• Investigation of glutamine and GABA levels in patients with idiopathic generalized epilepsy using MEGAPRESS

  2015cited by this paper
• The combined effect of genetic polymorphisms and clinical parameters on treatment outcome in treatment-resistant depression.

  2015cited by this paper
• Do the dissociative side effects of ketamine mediate its antidepressant effects?

  2014cited by this paper
• Multistage drug effects of ketamine in the treatment of major depression

  2014cited by this paper
• Ketamine administration in depressive disorders: a systematic review and meta-analysis

  2014cited by this paper
• A systematic review and meta-analysis of randomized, double-blind, placebo-controlled trials of ketamine in the rapid treatment of major depressive episodes

  2014cited by this paper
• Ketamine as the prototype glutamatergic antidepressant: pharmacodynamic actions, and a systematic review and meta-analysis of efficacy

  2014cited by this paper
• Dissociation of glutamate and cortical thickness is restricted to regions subserving trait but not state markers in major depressive disorder.

  2014cited by this paper
• Systematic Regional Variations of GABA, Glutamine, and Glutamate Concentrations Follow Receptor Fingerprints of Human Cingulate Cortex

  2013cited by this paper
• Ketamine as a Fast Acting Antidepressant: Current Knowledge and Open Questions

  2013cited by this paper
• Relationship of ketamine's antidepressant and psychotomimetic effects in unipolar depression.

  2013cited by this paper
• Region and state specific glutamate downregulation in major depressive disorder: a meta-analysis of (1)H-MRS findings.

  2012cited by this paper
• Antidepressant-like effects of low ketamine dose is associated with increased hippocampal AMPA/NMDA receptor density ratio in female Wistar-Kyoto rats.

  2012cited by this paper
• Ketamine Decreases Resting State Functional Network Connectivity in Healthy Subjects: Implications for Antidepressant Drug Action

  2012cited by this paper
• Lack of effect of ketamine on cortical glutamate and glutamine in healthy volunteers: a proton magnetic resonance spectroscopy study

  2012cited by this paper
• Proton magnetic resonance spectroscopy in deep human brain structures at 7 T

  2012cited by this paper
• A neurotrophic hypothesis of depression: role of synaptogenesis in the actions of NMDA receptor antagonists

  2012cited by this paper
• Ketamine for depression: where do we go from here?

  2012cited by this paper
• Involvement of AMPA receptor in both the rapid and sustained antidepressant-like effects of ketamine in animal models of depression.

  2011cited by this paper
• NMDA Receptor Blockade at Rest Triggers Rapid Behavioural Antidepressant Responses

  2011cited by this paper
• Neural mechanisms of the cognitive model of depression

  2011cited by this paper
• Frontocingulate Dysfunction in Depression: Toward Biomarkers of Treatment Response

  2011cited by this paper
• The case of the missing glutamine

  2011cited by this paper
• Magnetic resonance spectroscopy studies of the glutamatergic system in mood disorders: a pathway to diagnosis, novel therapeutics, and personalized medicine?

  2010cited by this paper
• Magnetic resonance spectroscopy studies of glutamate-related abnormalities in mood disorders.

  2010cited by this paper
• Rapid Enhancement of Glutamatergic Neurotransmission in Bipolar Depression Following Treatment with Riluzole

  2010cited by this paper
• Neurochemical changes in the rat prefrontal cortex following acute phencyclidine treatment: an in vivo localized 1H MRS study

  2009cited by this paper
• Increased anterior cingulate cortical activity in response to fearful faces: a neurophysiological biomarker that predicts rapid antidepressant response to ketamine.

  2009cited by this paper
• The relationship between aberrant neuronal activation in the pregenual anterior cingulate, altered glutamatergic metabolism, and anhedonia in major depression.

  2009cited by this paper
• Receptor architecture of human cingulate cortex: Evaluation of the four‐region neurobiological model

  2009cited by this paper
• Cellular mechanisms underlying the antidepressant effects of ketamine: role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors.

  2008cited by this paper
• Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders

  2008cited by this paper
• Brain imaging correlates of depressive symptom severity and predictors of symptom improvement after antidepressant treatment.

  2007cited by this paper
• A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.

  2006cited by this paper
• 1H MR spectroscopy of the brain: absolute quantification of metabolites.

  2006cited by this paper
• Effects of ketamine on anterior cingulate glutamate metabolism in healthy humans: a 4-T proton MRS study.

  2005cited by this paper
• Parameterized evaluation of macromolecules and lipids in proton MR spectroscopy of brain diseases

  2003cited by this paper
• Structural and functional dichotomy of human midcingulate cortex

  2003cited by this paper
• Glutamate and GABA systems as targets for novel antidepressant and mood-stabilizing treatments

  2002cited by this paper
• Anterior cingulate activity as a predictor of degree of treatment response in major depression: evidence from brain electrical tomography analysis.

  2001cited by this paper
• Antidepressant effects of ketamine in depressed patients.

  2000cited by this paper
• Cognitive and emotional influences in anterior cingulate cortex.

  2000cited by this paper
• Reduced glutamate in the anterior cingulate cortex in depression: an in vivo proton magnetic resonance spectroscopy study.

  2000cited by this paper
• Cingulate function in depression: a potential predictor of treatment response

  1997cited by this paper

• Ketamine for unipolar depression: A systematic review of efficacy and safety

  2025cites this paper
• Modulation of Magnetic Resonance Spectroscopy Levels of Glutamate and GABA by Ketamine in Treatment‐Resistant Depression

  2025cites this paper
• Concurrent assessment of neurometabolism and brain hemodynamics to characterize the functional brain response to psychotropic drugs: an S-ketamine study.

  2025cites this paper
• Association between S-ketamine induced changes in glutamate levels in the pregenual anterior cingulate cortex and plasma brain-derived neurotrophic factor in healthy subjects

  2025cites this paper
• Effects of esketamine on electrophysiology and metabolic reprogramming in brain organoids: insights into antidepressant mechanisms

  2025cites this paper
• Appetite measures as correlates of clinical response in mood disorders treated with ketamine: systematic review

  2025cites this paper
• Resting‐State Electroencephalogram Complexity Is Associated With Oral Ketamine Treatment Response: A Bayesian Analysis of Lempel–Ziv Complexity and Multiscale Entropy

  2024cites this paper
• Beyond NMDA Receptors: A Narrative Review of Ketamine’s Rapid and Multifaceted Mechanisms in Depression Treatment

  2024cites this paper
• Negative emotionality shapes the modulatory effects of ketamine and lamotrigine in subregions of the anterior cingulate cortex

  2024cites this paper
• Association of the delayed changes in glutamate levels and functional connectivity with the immediate network effects of S-ketamine

  2023cites this paper
• Reverse engineering therapeutic mechanisms of ketamine and Psychedelics: Insights from Translational Oncology for Research in Psychiatry

  2023cites this paper
• Neurometabolite changes in response to antidepressant medication: A systematic review of 1H-MRS findings

  2023influential citation
• The contribution of polyamine pathway to determinations of diagnosis for treatment-resistant depression: A metabolomic analysis.

  2023cites this paper
• Effects of Psychotherapy on Glutamatergic Neurotransmission

  2023cites this paper
• Label-Free Chemically and Molecularly Selective Magnetic Resonance Imaging

  2023cites this paper
• Ketamine and Zinc: Treatment of Anorexia Nervosa Via Dual NMDA Receptor Modulation

  2023cites this paper
• Protocol for the Ketamine for Postoperative Avoidance of Depressive Symptoms (K-PASS) feasibility study: A randomized clinical trial

  2022cites this paper
• Predicting Antidepressant Effects of Ketamine: the Role of the Pregenual Anterior Cingulate Cortex as a Multimodal Neuroimaging Biomarker

  2022cites this paper
• Acute effects of ketamine on the pregenual anterior cingulate: linking spontaneous activation, functional connectivity, and glutamate metabolism

  2022cites this paper
• Glutamate and GABA Homeostasis and Neurometabolism in Major Depressive Disorder

  2021cites this paper
• Effect of Ketamine on Human Neurochemistry in Posterior Cingulate Cortex: A Pilot Magnetic Resonance Spectroscopy Study at 3 Tesla

  2021cites this paper
• The anterior cingulate cortex as a key locus of ketamine's antidepressant action.

  2021cites this paper
• Glycogen Synthase Kinase-3: A Focal Point for Advancing Pathogenic Inflammation in Depression

  2021cites this paper
• Nitrous Oxide: an emerging novel treatment for treatment-resistant depression.

  2021cites this paper
• Ketamine-induced changes in plasma brain-derived neurotrophic factor (BDNF) levels are associated with the resting-state functional connectivity of the prefrontal cortex

  2020cites this paper
• Effect of Ketamine on Limbic GABA and Glutamate: A Human In Vivo Multivoxel Magnetic Resonance Spectroscopy Study

  2020cites this paper
• Drug repositioning for treatment-resistant depression: Hypotheses from a pharmacogenomic study.

  2020cites this paper
• Localized Prediction of Glutamate from Whole-Brain Functional Connectivity of the Pregenual Anterior Cingulate Cortex

  2020cites this paper
• Altered neurometabolism in major depressive disorder: A whole brain 1H-magnetic resonance spectroscopic imaging study at 3T.

  2020cites this paper
• The potential of 1H-MRS in CNS drug development

  2019cites this paper
• Updates on Preclinical and Translational Neuroscience of Mood Disorders: A Brief Historical Focus on Ketamine for the Clinician.

  2019cites this paper
• Rostral Anterior Cingulate Glutamine/Glutamate Disbalance in Major Depressive Disorder Depends on Symptom Severity.

  2019cites this paper
• Can we increase the speed and efficacy of antidepressant treatments? Part II. Glutamatergic and RNA interference strategies.

  2018cites this paper
• Default mode network connectivity change corresponds to ketamine’s delayed glutamatergic effects

  2018cites this paper
• Intraoperative ketamine for prevention of depressive symptoms after major surgery in older adults: an international, multicentre, double‐blind, randomised clinical trial

  2018cites this paper
• Ten-Hour Exposure to Low-Dose Ketamine Enhances Corticostriatal Cross-Frequency Coupling and Hippocampal Broad-Band Gamma Oscillations

  2018cites this paper
• Effect of electroconvulsive therapy on neural response to affective pictures: A randomized, sham-controlled fMRI study.

  2018cites this paper
• Behavioral and biochemical sensitivity to low doses of ketamine: Influence of estrous cycle in C57BL/6 mice

  2018cites this paper
• 7T 1H-MRS in major depressive disorder: a Ketamine Treatment Study

  2018cites this paper
• Ketamine and its metabolite (2R,6R)-hydroxynorketamine induce lasting alterations in glutamatergic synaptic plasticity in the mesolimbic circuit

  2018cites this paper
• Glutamate Levels and Resting Cerebral Blood Flow in Anterior Cingulate Cortex Are Associated at Rest and Immediately Following Infusion of S-Ketamine in Healthy Volunteers

  2018cites this paper
• GAD65 Promoter Polymorphism rs2236418 Modulates Harm Avoidance in Women via Inhibition/Excitation Balance in the Rostral ACC

  2018cites this paper
• Targeting glutamate signalling in depression: progress and prospects

  2017cites this paper
• Ketamine Has Distinct Electrophysiological and Behavioral Effects in Depressed and Healthy Subjects

  2017cites this paper
• Richness in Functional Connectivity Depends on the Neuronal Integrity within the Posterior Cingulate Cortex

  2017cites this paper